Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL
Clinical trial NCT00452374 · COMPLETED
Trial details
- NCT number
- NCT00452374
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-11-01
- Primary completion
- 2011-01-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.